Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioqualBIOQ 54 Dividend Payout Ratio is 0.00 as of Nov. 2025. GuruFocus rates BIOQ with a GF Score™ of 54/100. The stock has 4 warning signs investors should review. Among 54 Medical Diagnostics & Research companies, Bioqual ranks worse than 1851850% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bioqual's Dividend Payout Ratio for the
months ended in Nov. 2025 was 0.00.
The historical rank and industry rank for Bioqual's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Bioqual was 0.36. The lowest was 0.08. And the median was 0.13.
BIOQ's Dividend Payout Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.54 * Ranked among companies with meaningful Dividend Payout Ratio only.
During the past 3 years, the average Dividends Per Share Growth Rate was 55.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 45.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bioqual was 59.90% per year. The lowest was 17.00% per year. And the median was 43.55% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Bioqual (OTCPK:BIOQ) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Bioqual Dividend Payout Ratio Related Terms
Bioqual Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Bioqual's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIOQ vs ADVB, QUCY, MDXH: Dividend Payout Ratio Comparison
For the Diagnostics & Research subindustry, Bioqual's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioqual Dividend Payout Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Bioqual's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Bioqual's Dividend Payout Ratio for the fiscal year that ended in May. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioqual (BIOQ) has a Dividend Payout Ratio of 0.00 as of Nov. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bioqual and its competitors. Over the past decade, Bioqual's Dividend Payout Ratio has ranged from 0.08 to 0.36. According to the industry distribution chart, Bioqual ranks #999999 out of 54 companies in the Medical Diagnostics & Research industry.
Is Bioqual's Dividend Payout Ratio too high?
Bioqual's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 0.36. Based on the distribution chart, Bioqual ranks #999999 out of 54 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Bioqual has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Bioqual's Dividend Payout Ratio compare to ADVB and QUCY?
According to the Medical Diagnostics & Research industry distribution chart, Bioqual ranks #999999 out of 54 companies for Dividend Payout Ratio. This places Bioqual in the lower half of its industry. The industry median Dividend Payout Ratio is 0.54. Historically, Bioqual's own Dividend Payout Ratio has ranged from 0.08 to 0.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.54, based on 54 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bioqual and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioqual's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioqual stock overvalued right now?
Bioqual (BIOQ) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Bioqual's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Bioqual (BIOQ), the current Dividend Payout Ratio is 0.00 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
54GF Score
Get the complete analysis for BIOQ
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOQ has been successfully added to your 
